HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helena M Earl Selected Research

Glucose (Dextrose)

1/2016A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helena M Earl Research Topics

Disease

25Breast Neoplasms (Breast Cancer)
04/2024 - 11/2006
11Neoplasms (Cancer)
01/2020 - 11/2006
8Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 12/2007
4Cardiotoxicity
01/2020 - 12/2016
3Ovarian Epithelial Carcinoma
01/2020 - 03/2016
3Carcinoma (Carcinomatosis)
12/2019 - 01/2012
3Neutropenia
01/2017 - 12/2015
3Neoplasm Metastasis (Metastasis)
01/2017 - 08/2010
3Sarcoma (Soft Tissue Sarcoma)
01/2015 - 01/2005
2Nausea
01/2017 - 08/2014
2Fatigue
01/2017 - 08/2014
1Triple Negative Breast Neoplasms
04/2024
1Vomiting
01/2017
1Myalgia
01/2017
1Arthralgia (Joint Pain)
01/2017
1Infections
01/2017
1Cardiovascular Diseases (Cardiovascular Disease)
12/2016
1Genetic Risk Score
01/2016
1Coronary Disease (Coronary Heart Disease)
01/2016
1Obesity
12/2015
1Anemia
08/2014
1Leiomyosarcoma
08/2014
1Liposarcoma
08/2014
1Medulloblastoma
07/2009
1Hypoxia (Hypoxemia)
01/2005

Drug/Important Bio-Agent (IBA)

8Paclitaxel (Taxol)FDA LinkGeneric
04/2024 - 12/2007
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 11/2006
6AnthracyclinesIBA
04/2024 - 11/2006
5Epirubicin (Ellence)FDA LinkGeneric
01/2017 - 11/2006
4Trastuzumab (Herceptin)FDA Link
01/2020 - 12/2016
4taxaneIBA
01/2017 - 05/2014
4Fluorouracil (Carac)FDA LinkGeneric
06/2015 - 11/2006
3Carboplatin (JM8)FDA LinkGeneric
04/2024 - 12/2019
3PlatinumIBA
01/2020 - 04/2012
3Estrogen ReceptorsIBA
12/2017 - 11/2006
3Cisplatin (Platino)FDA LinkGeneric
03/2016 - 07/2009
3Methotrexate (Mexate)FDA LinkGeneric
05/2015 - 11/2006
2Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2016
2ParaffinIBA
11/2017 - 01/2016
2Formaldehyde (Formol)FDA Link
11/2017 - 01/2016
2GemcitabineFDA Link
01/2017 - 02/2014
2DNA (Deoxyribonucleic Acid)IBA
12/2016 - 01/2010
2Genetic Markers (Genetic Marker)IBA
01/2016 - 05/2015
2Docetaxel (Taxotere)FDA Link
06/2015 - 08/2010
2TamoxifenFDA LinkGeneric
06/2011 - 01/2010
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
06/2011 - 01/2010
1olaparibIBA
04/2024
1rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA
01/2020
1trans-sodium crocetinate (crocetin)IBA
01/2019
1SodiumIBA
01/2019
1Hormones (Hormone)IBA
01/2017
1Etoposide (VP 16)FDA LinkGeneric
03/2016
1Complementary DNA (cDNA)IBA
01/2016
1Phenobarbital (Luminal)FDA Link
01/2016
1RNA (Ribonucleic Acid)IBA
01/2016
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Bevacizumab (Avastin)FDA Link
06/2015
1Topotecan (Hycamtin)FDA LinkGeneric
01/2015
1Transaminases (Aminotransferases)IBA
08/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
08/2014
1TrabectedinIBA
08/2014
1Taxoids (Taxanes)IBA
02/2014
11- (ethoxycarbonyloxymethyl)- 5- fluorouracilIBA
09/2013
1nintedanibIBA
01/2012
1CytochromesIBA
06/2011
1EnzymesIBA
06/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2010
1Transforming Growth Factor beta (TGF-beta)IBA
12/2007
1Extracellular Matrix ProteinsIBA
12/2007
1Proteins (Proteins, Gene)FDA Link
12/2007

Therapy/Procedure

19Drug Therapy (Chemotherapy)
04/2024 - 01/2005
7Neoadjuvant Therapy
01/2022 - 04/2012
6Therapeutics
01/2022 - 11/2006
5Adjuvant Chemotherapy
01/2017 - 09/2013
1Treatment Delay
12/2016
1Ligation
01/2016
1Radiofrequency Ablation
01/2015
1Blood Transfusion (Blood Transfusions)
01/2005
1Radiotherapy
01/2005